Short-Term Effect of Autogenic Drainage on Ventilation Inhomogeneity in Adult Subjects With Stable Non-Cystic Fibrosis Bronchiectasis

References

1. 1.↵
   1. Barker AF

   . Bronchiectasis. N Engl J Med 2002;346(18):1383–1393.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. McDonnell MJ,
   2. Ward C,
   3. Lordan JL,
   4. Rutherford RM

   . Non-cystic fibrosis bronchiectasis. QJM 2013;106(8):709–715.

   OpenUrlAbstract/FREE Full Text
3. 3.
   1. Loebinger MR,
   2. Wells AU,
   3. Hansell DM,
   4. Chinyanganya N,
   5. Devaraj A,
   6. Meister M,
   7. Wilson R

   . Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009;34(4):843–849.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. McShane PJ,
   2. Naureckas ET,
   3. Tino G,
   4. Strek ME

   . Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2013;188(6):647–656.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Pasteur MC,
   2. Bilton D,
   3. Hill AT

   . British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65(Suppl 1):i1–58.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Lee AL,
   2. Burge AT,
   3. Holland AE

   . Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2015;(11):CD008351.
7. 7.
   1. Herrero-Cortina B,
   2. Vilaró J,
   3. Martí D,
   4. Torres A,
   5. San Miguel-Pagola M,
   6. Alcaraz V,
   7. Polverino E

   . Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy 2016;102(4):357–364.

   OpenUrl
8. 8.↵
   1. Snijders D,
   2. Fernandez Dominguez B,
   3. Calgaro S,
   4. Bertozzi I,
   5. Escribano Montaner A,
   6. Perilongo G,
   7. Barbato A

   . Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: is there evidence? Int J Immunopathol Pharmacol 2015;28(2):150–159.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Smith MP,
   2. Hill AT

   . Evaluating success of therapy for bronchiectasis: what end points to use? Clin Chest Med 2012;33(2):329–349.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Stanojevic S,
    2. Ratjen F

    . Physiologic endpoints for clinical studies for cystic fibrosis. J Cyst Fibros 2016;15(4):416–423.

    OpenUrl
11. 11.↵
    1. Gonem S,
    2. Scadding A,
    3. Soares M,
    4. Singapuri A,
    5. Gustafsson P,
    6. Ohri C,
    7. et al

    . Lung clearance index in adults with non-cystic fibrosis bronchiectasis. Respir Res 2014;15:59.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Grillo L,
    2. Irving S,
    3. Hansell DM,
    4. Nair A,
    5. Annan B,
    6. Ward S,
    7. et al

    . The reproducibility and responsiveness of the lung clearance index in bronchiectasis. Eur Respir J 2015;46(6):1645–1653.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Rowan SA,
    2. Bradley JM,
    3. Bradbury I,
    4. Lawson J,
    5. Lynch T,
    6. Gustafsson P,
    7. et al

    . Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. Am J Respir Crit Care Med 2014;189(5):586–592.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Chalmers JD,
    2. Goeminne P,
    3. Aliberti S,
    4. McDonnell MJ,
    5. Lonni S,
    6. Davidson J,
    7. et al

    . The bronchiectasis severity index: an international derivation and validation study. Am J Respir Crit Care Med 2014;189(5):576–585.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Robinson PD,
    2. Latzin P,
    3. Verbanck S,
    4. Hall GL,
    5. Horsley A,
    6. Gappa M,
    7. et al

    . Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J 2013;41(3):507–522.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Robinson PD,
    2. Stocks J,
    3. Aurora P,
    4. Lum S

    . Abbreviated multi-breath washout for calculation of lung clearance index. Pediatr Pulmonol 2013;48(4):336–343.

    OpenUrl
17. 17.↵
    1. Yammine S,
    2. Singer F,
    3. Abbas C,
    4. Roos M,
    5. Latzin P

    . Multiple-breath washout measurements can be significantly shortened in children. Thorax 2013;68(6):586–587.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Cole TJ,
    4. Baur X,
    5. Hall GL,
    6. Culver BH,
    7. et al

    . Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324–1343.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Pistelli F,
    2. Bottai M,
    3. Viegi G,
    4. Di Pede F,
    5. Carrozzi L,
    6. Baldacci S,
    7. et al

    . Smooth reference equations for slow vital capacity and flow-volume curve indexes. Am J Respir Crit Care Med 2000;161(3 Pt 1):899–905.

    OpenUrlPubMedWeb of Science
21. 21.↵
    1. Stocks J,
    2. Quanjer PH

    . Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J 1995;8(3):492–506.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Guan WJ,
    2. Chen RC,
    3. Zhong NS

    . The bronchiectasis severity index and FACED score for bronchiectasis. Eur Respir J 2016;47(2):382–384.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Pryor JA

    . Physiotherapy for airway clearance in adults. Eur Respir J 1999;14(6):1418–1424.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Agostini P,
    2. Knowles N

    . Autogenic drainage: the technique, physiological basis and evidence. Physiotherapy 2007;93(2):157–163.

    OpenUrl
25. 25.↵
    1. Singer F,
    2. Kieninger E,
    3. Abbas C,
    4. Yammine S,
    5. Fuchs O,
    6. Proietti E,
    7. et al

    . Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr Pulmonol 2013;48(8):739–746.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Bland JM,
    2. Altman DG

    . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307–310.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Fuchs SI,
    2. Toussaint S,
    3. Edlhaimb B,
    4. Ballmann M,
    5. Gappa M

    . Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol 2010;45(3):301–306.

    OpenUrlPubMedWeb of Science
28. 28.↵
    1. Pfleger A,
    2. Steinbacher M,
    3. Schwantzer G,
    4. Weinhandl E,
    5. Wagner M,
    6. Eber E

    . Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with a wide range of lung disease severity. J Cyst Fibros 2015;14(5):627–631.

    OpenUrl
29. 29.↵
    1. Ratjen F,
    2. Döring G

    . Cystic fibrosis. Lancet 2003;361(9358):681–689.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.
    1. Bannier E,
    2. Cieslar K,
    3. Mosbah K,
    4. Aubert F,
    5. Duboeuf F,
    6. Salhi Z,
    7. et al

    . Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function. Radiology 2010;255(1):225–232.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Sun Y,
    2. O'Sullivan BP,
    3. Roche JP,
    4. Walvick R,
    5. Reno A,
    6. Baker D,
    7. et al

    . Using hyperpolarized 3He MRI to evaluate treatment efficacy in cystic fibrosis patients. J Magn Reson Imaging 2011;34(5):1206–1211.

    OpenUrlPubMed
32. 32.↵
    1. Lin B,
    2. Yabsley P,
    3. Middleton A,
    4. Robinson P,
    5. Jaffe A,
    6. Selvadurai H

    . Acute changes in the lung clearance index after physiotherapy in children with cystic fibrosis. J Cyst Fibros 2015;14(Suppl 1):S39.

    OpenUrl
33. 33.↵
    1. Rodriguez Hortal MC,
    2. Hjelte L

    . Time point to perform lung function tests evaluating the effects of an airway clearance therapy session in cystic fibrosis. Respir Care 2014;59(10):1537–1541.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    1. Ruppel GL

    . What is the clinical value of lung volumes? Respir Care 2012;57(1):26–35; discussion 35-38.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Clermons K,
    2. Cornelussen S,
    3. Martin L,
    4. Bongaerts P,
    5. Van der Grinten C

    . Selecting a multiple-breath N2 washout device: the search continues. Eur Respir J 2015;46(suppl):59.

    OpenUrl
36. 36.
    1. Raaijmakers L,
    2. Jensen R,
    3. Stanojevic S,
    4. Merkus P,
    5. Ratjen F

    . In vitro and in vivo comparison of two multiple breath nitrogen washout devices. Eur Respir J 2015;46(suppl):59.

    OpenUrl
37. 37.
    1. Raywood E,
    2. Duncan J,
    3. Wade A,
    4. Stocks J,
    5. Bush A,
    6. Aurora P

    . Validation of commercial devices for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in school-aged children. Eur Respir J 2015;46(suppl):59.

    OpenUrl
38. 38.↵
    1. Zuo L,
    2. Pannell BK,
    3. Horsley A,
    4. Bell N,
    5. Kane M,
    6. Ratjen F,
    7. et al

    . Commentaries on viewpoint: using the same cut-off for sulfur hexafluoride and nitrogen multiple-breath washout may not be appropriate. J Appl Physiol 2015;119(12):1513–1514.

    OpenUrlFREE Full Text
39. 39.↵
    1. Smith BM,
    2. Hoffman EA,
    3. Basner RC,
    4. Kawut SM,
    5. Kalhan R,
    6. Barr RG

    . Not all measures of hyperinflation are created equal: lung structure and clinical correlates of gas trapping and hyperexpansion in COPD: the multi-ethnic study of atherosclerosis (MESA) COPD study. Chest 2014;145(6):1305–1315.

    OpenUrl